The Pathology of Experimental Poxvirus Infection in Common Marmosets (Callithrix jacchus): Further Characterization of a New Primate Model for Orthopoxvirus Infections

Journal of Comparative Pathology

Volumn 146, Issue 2-3, 2012, Pages 230-242

  Matz Rensing K ^a   Stahl Hennig, C ^a   Kramski, M ^b,c   Pauli, G ^b   Ellerbrok, H ^b   Kaup, F J ^a  

^a GERMAN PRIMATE CENTER   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Callithrix jacchus; Calpox virus; Common marmoset; Non human primate model

Indexed keywords

SMALLPOX VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALLITRICHINAE; CALPOX VIRUS; CALPOX VIRUS INFECTION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; INOCULATION; LIVER; LYMPH NODE; MALE; MUCOSA; NONHUMAN; ORTHOPOXVIRUS; ORTHOPOXVIRUS INFECTION; POXVIRUS; POXVIRUS INFECTION; PRIORITY JOURNAL; SKIN; SMALLPOX; SMALLPOX VIRUS; SPLEEN; VIRUS ISOLATION;

ANIMALS; CALLITHRIX; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; LIVER; MALE; ORTHOPOXVIRUS; POXVIRIDAE INFECTIONS; SPLEEN;

ANIMALIA; CALLITHRIX JACCHUS; MARMOSETS; ORTHOPOXVIRUS; POXVIRIDAE; PRIMATES; VARIOLA VIRUS;

EID: 84858625032     PISSN: 00219975     EISSN: 15323129     Source Type: Journal    
DOI: 10.1016/j.jcpa.2011.06.003     Document Type: Article

References (31)

1. Baxby D., Ashton D.G., Jones D., Thomsett L.R., Denham E.M. Cowpox virus infection in unusual hosts. Veterinary Record 1979, 104:175.
2. Baxby D., Bennett M., Getty B. Human cowpox 1969-93: a review based on 54 cases. British Journal of Dermatology 1994, 131:598-607.
3. Begon M., Hazel S.M., Baxby D., Bown K., Cavanagh R., et al. Transmission dynamics of a zoonotic pathogen within and between wildlife host species. Proceedings of Biological Science 1999, 266:1939-1945.
4. Campe H., Zimmermann P., Glos K., Bayer M., Bergemann H., et al. Cowpox virus transmission from pet rats to humans, Germany. Emerging Infectious Diseases 2009, 15:777-780.
5. Centers for Disease Control and Prevention Multistate outbreak of monkeypox - Illinois, Indiana, and Wisconsin. Morbidity and Mortality Weekly Report 2003, 52:537-540.
6. Chantrey J., Meyer H., Baxby D., Begon M., Bown K.J., et al. Cowpox: reservoir hosts and geographic range. Epidemiology and Infection 1999, 122:455-460.
7. Czerny C.P., Eis-Hubinger A.M., Mayr A., Schneweis K.E., Pfeiff B. Animal poxviruses transmitted from cat to man: current event with lethal end. Zentralbl Veterinarmed B 1991, 38:421-431.
8. DiGiulio D.B., Eckburg P.B. Monkeypox in the Western hemisphere. New England Journal of Medicine 2004, 350:1790-1791.
9. Earl P.L., Americo J.L., Wyatt L.S., Eller L.A., Whitbeck J.C., et al. Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox. Nature 2004, 428:182-185.
10. Edghill-Smith Y., Golding H., Manischewitz J., King L.R., Scott D., et al. Smallpox vaccine induced antibodies are necessary and sufficient for protection against monkeypox virus. Nature Medicine 2005, 11:740-747.
11. Eis-Hübinger A.M., Gerritzen A., Schneweis K.E., Pfeiff B., Puzllmann H., et al. Fatal cowpox-like virus infection transmitted by cat. Lancet 1990, 336:880.
12. Esposito J.J., Fenner F. Poxviruses. Fields' Virology 2001, Vol. 2:2887-2921. Lippincott, Williams & Wilkins, Philadelphia. 4th Edit. D.M. Knipe, P.M. Howley, D.E. Griffin, R.A. Lamb, M.A. Martin (Eds.).
13. Fenner F., Henderson D.A., Arita I., Jezek Z., Ladnyi I.D. Pathogenesis, Pathology and Immunology of Smallpox; Smallpox and its Eradication 1988, World Health Organization, Geneva, pp. 121-168.
14. Hazel S.M., Bennett M., Chantrey J., Brown J., Cavanagh R., et al. A longitudinal study of an endemic disease in its wildlife reservoir: cowpox and wild rodents. Epidemiology and Infection 2000, 124:551-562.
15. Hooper J.W., Thompson E., Wilhelmsen C., Zimmerman M., Ichou M.A., et al. Smallpox DNA vaccine protects non-human primates against lethal monkeypox. Journal of Virology 2004, 78:4433-4443.
16. Jahrling P.B., Hensley L.E., Martinez M.J., Leduc J.W., Rubins K.H., et al. Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox. Proceedings of the National Academy of Sciences USA 2004, 101:15196-15200.
17. Jezek Z., Szczeniowski M., Paluku K., Mutombo M. Human monkeypox: clinical features of 282 patients. Journal of Infectious Diseases 1987, 156:293-298.
18. Kramski M., Mätz-Rensing K., Stahl-Hennig C., Kaup F.-J., Nitsche A., et al. A novel highly reproducible and lethal nonhuman primate model for orthopox virus infection. PLoS One 2010, 5:e10412.
19. Kurth A., Straube M., Kuczka A., Dunsche A.J., Meyer H., et al. Cowpox virus outbreak in banded mongooses (Mungos mungo) and jaguarundis (Herpailurus yagouaroundi) with a time-delayed infection to humans. PLoS One 2009, 4:e6883.
20. LeDuc J.W., Jahrling P.B. Strengthening national preparedness for smallpox: an update. Emerging Infectious Diseases 2001, 7:155-157.
21. Mätz-Rensing K., Ellerbrok H., Ehlers B., Pauli G., Floto A., et al. Fatal poxvirus outbreak in a colony of New World monkeys. Veterinary Pathology 2006, 43:212-218.
22. Marriott KA (2008) Characterization and description of a respiratory challenge model of poxvirus infection. Proceedings of the 17th International Poxvirus and Iridovirus Conference, Grainau, Germany, June 7-12.
23. Nalca A., Rimoin A.W., Bavari S., Whitehouse C.A. Reemergence of monkeypox: prevalence, diagnostics, and countermeasures. Clinical Infectious Diseases 2005, 41:1765-1771.
24. Parker S., Nuara A., Buller R.M., Schultz D.A. Human monkey pox: an emerging zoonotic disease. Future Microbiology 2007, 2:17-34.
25. Pilaski J., Rosen A., Darai G. Comparative analysis of the genomes of orthopoxviruses isolated from elephant, rhinoceros, and okapi by restriction enzymes. Archives of Virology 1986, 88:135-142.
26. Rubins K.H., Hensley L.E., Jahrling P.B., Whitney A.R., Geisbert T.W., et al. The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a non-human primate model. Proceedings of the National Academy of Sciences USA 2004, 101:15190-15195.
27. Saijo M., Ami Y., Suzaki Y., Nagata N., Iwata N., et al. LC16m8, a highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypox. Journal of Virology 2006, 80:5179-5188.
28. Stittelaar K.J., Neyts J., Naesens L., van Amerongen G., van Lavieren R.F., et al. Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection. Nature 2006, 439:745-748.
29. Stittelaar K.J., van Amerongen G., Kondova I., Kuiken T., van Lavieren R.F., et al. Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus. Journal of Virology 2005, 79:7845-7851.
30. Vorou R.M., Papavassiliou V.G., Pierroutsakos I.N. Cowpox virus infection: an emerging health threat. Current Opinion in Infectious Disease 2008, 21:153-156.
31. Zaucha G.M., Jahrling P.B., Geisbert T.W., Swearengen J.R., Hensley L. The pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (Macaca fascicularis). Laboratory Investigation 2001, 81:1581-1600.